Cranberry Extract Standardized for Proanthocyanidins Alleviates β-Amyloid Peptide Toxicity by Improving Proteostasis Through HSF-1 in Caenorhabditis elegans Model of Alzheimer's Disease

J Gerontol A Biol Sci Med Sci. 2016 Dec;71(12):1564-1573. doi: 10.1093/gerona/glv165. Epub 2015 Sep 23.

Abstract

A growing body of evidence suggests that nutraceuticals with prolongevity properties may delay the onset of Alzheimer's disease (AD). We recently demonstrated that a proanthocyanidins-standardized cranberry extract has properties that prolong life span and promote innate immunity in Caenorhabditis elegans In this article, we report that supplementation of this cranberry extract delayed Aβ toxicity-triggered body paralysis in the C elegans AD model. Genetic analyses indicated that the cranberry-mediated Aβ toxicity alleviation required heat shock transcription factor (HSF)-1 rather than DAF-16 and SKN-1. Moreover, cranberry supplementation increased the transactivity of HSF-1 in an IIS-dependent manner. Further studies found that the cranberry extract relies on HSF-1 to significantly enhance the solubility of proteins in aged worms, implying an improved proteostasis in AD worms. Considering that HSF-1 plays a pivotal role in maintaining proteostasis, our results suggest that cranberry maintains the function of proteostasis through HSF-1, thereby protecting C elegans against Aβ toxicity. Together, our findings elucidated the mechanism whereby cranberry attenuated Aβ toxicity in C elegans and stressed the significance of proteostasis in the prevention of age-related diseases from a practical point of view.

Keywords: Caenorhabditis elegans; hsf-1; Alzheimer’s disease; Cranberry; Proteostasis; β-Amyloid.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Intramural

MeSH terms

  • Aging / drug effects*
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / immunology*
  • Amyloid beta-Peptides / toxicity*
  • Animals
  • Animals, Genetically Modified
  • Caenorhabditis elegans / drug effects*
  • Caenorhabditis elegans Proteins / biosynthesis*
  • DNA-Binding Proteins / drug effects
  • Disease Models, Animal
  • Forkhead Transcription Factors
  • Heat Shock Transcription Factors
  • Immunity, Innate
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Proanthocyanidins / chemistry
  • Proanthocyanidins / pharmacology*
  • Protective Agents / chemistry
  • Protective Agents / pharmacology*
  • Signal Transduction
  • Transcription Factors / drug effects
  • Vaccinium macrocarpon*

Substances

  • Amyloid beta-Peptides
  • Caenorhabditis elegans Proteins
  • DNA-Binding Proteins
  • Forkhead Transcription Factors
  • Heat Shock Transcription Factors
  • Plant Extracts
  • Proanthocyanidins
  • Protective Agents
  • Transcription Factors
  • daf-16 protein, C elegans
  • heat shock factor-1, C elegans
  • skn-1 protein, C elegans